Pettinga Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Pettinga Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,730	Closed	-$202K	–	105
2022 Q3	$202K	Sell	1,730 -1,275	-42%	-$158K	0.07%	91
2022 Q2	$353K	Sell	3,005 -2,881	-49%	-$342K	0.11%	80
2022 Q1	$767K	Sell	5,886 -585	-9%	-$76.2K	0.19%	63
2021 Q4	$988K	Buy	+6,471	New	+$1M	0.24%	58
2021 Q2	–	Sell	-1,389	Closed	-$209K	–	114
2021 Q1	$209K	Buy	+1,389	New	+$221K	0.06%	94
2020 Q2	–	Sell	-3,225	Closed	-$347K	–	81
2020 Q1	$347K	Buy	+3,225	New	+$371K	0.23%	54

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Pettinga Financial Advisors's IBB Position: Q4 2022 in Review

Pettinga Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 1,730 shares — an estimated $202K sold.

Pettinga Financial Advisors first reported a position in IBB in Q1 2020 and held it in 6 quarters. The position peaked at $988K in Q4 2021. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

Pettinga Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
Pettinga Financial Advisors sold 1,730 iShares Biotechnology ETF shares in Q4 2022, an estimated $202K.
Pettinga Financial Advisors first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 6 quarters.
Pettinga Financial Advisors's iShares Biotechnology ETF position peaked at $988K in Q4 2021.
902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Pettinga Financial Advisors's 13F filing for Q4 2022, filed 13 Jan 2023.